clinical trial · NCT06774859
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms
Hoffmann-La Roche·phase3·completed·n = 100
InfluenzaBaloxavir MarboxilOseltamivir
brief summary
The purpose of this study is to evaluate the safety of a single dose baloxavir marboxil compared with 5 days of oseltamivir administered twice a day (BID) in Chinese pediatric participants aged 1 to \< 12 years with influenza symptoms.
started
Oct 27, 2024
primary completion
May 8, 2025
completion
May 8, 2025
last updated
May 18, 2025
official title
A Phase III, Randomized, Open-Label, Active-Controlled Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Patients 1 to <12 Years of Age With Influenza Symptoms
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol